The HT-cetuximab combination affected neither the cell survival ability (Figure 10A–10C) nor EGFR expression levels in CCD-18Co cells or in differentiated CaCo2 cells (Figure 10D), indicating that its effect is specific for tumor cells. This evidence concerns the gene EGFR and neoplasm.